drugset
drugset / Trial / NCT01362673

PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions

NCT01362673 ↗

Phase 1 Completed 27 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

This Phase 1 study is the first clinical trial in Japanese subjects. This study is designed to evaluate the single- and multiple-dose pharmacokinetics, safety and tolerability of PF-04171327 oral tablet in healthy adult Japanese and Western subjects in fasting and fed conditions.

Timeline

Start
2011-05
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject fosdagrocorat Small molecule 5 mg Oral
Subject fosdagrocorat Small molecule 10 mg Oral
Subject fosdagrocorat Small molecule 20 mg Oral
Subject fosdagrocorat Small molecule 30 mg Oral

Indications

No indication recorded.